NEW YORK (GenomeWeb) – French molecular diagnostics firm Genomic Vision reported today a roughly 21 percent drop in full-year 2016 revenues, reflecting a sharp decrease in revenues from its collaboration with Quest Diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.